Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Molecular Carcinogenesis|August 28, 2015
The Trp53 delta proline (Trp53ΔP) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor developmentCassandra J Adams, Jennifer S Yu, Jian-Hua Mao, et al.Cell Reports|December 12, 2019
DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS ClustersMargie N Sutton, Zhen Lu, Yao-Cheng Li, et al.Nature|December 8, 2022
Structural variants drive context-dependent oncogene activation in cancerZhichao Xu, Dong-Sung Lee, Sahaana Chandran, et al.Plos One|December 7, 2017
Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapyMaya Saison-Ridinger, Kathleen E DelGiorno, Tejia Zhang, et al.Nature Cell Biology|January 12, 2023
Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growthRui Tang, Emily G Shuldiner, Marcus Kelly, et al.Cell Reports|August 9, 2018
Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland DevelopmentRajshekhar R Giraddi, Chi-Yeh Chung, Richard E Heinz, et al.Gastro Hep Advances|October 24, 2022
Eicosanoids in the pancreatic tumor microenvironment - a multicellular, multifaceted progressionVikas B Gubbala, Nidhi Jytosana, Vincent Q Trinh, et al.Cellular and Molecular Gastroenterology and Hepatology|January 31, 2026
Pcdh20 is a POU2F3 target gene required for proper tuft cell microvillus organizationKatherine E Ankenbauer, Yilin Yang, Chi-Yeh Chung, et al.Nature|February 9, 2017
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneityKristen M Turner, Viraj Deshpande, Doruk Beyter, et al.Nature Communications|February 23, 2016
Establishment of human iPSC-based models for the study and targeting of glioma initiating cellsIgnacio Sancho-Martinez, Emmanuel Nivet, Yun Xia, et al.Pageof 8